2025-02-13

Strategic Cooperation between Tofflon OSD BU and Nicomac


Tofflon OSD BU, a division of Tofflon Group, has entered into a strategic cooperation agreement with Nicomac Mangini (hereinafter referred to as Nicomac), an internationally renowned pharmaceutical equipment manufacturer, in the field of oral solid dosage equipment. This cooperation will open up a vast market opportunity for both sides and is committed to meeting the high standards of equipment required by European customers, marking the deep cooperation between the two sides in the global pharmaceutical equipment field.


微信图片_20250213100258.jpg



1. The strength of both parties reveals the roots of cooperation

Since its founding in Milan, Italy, in 1977, Nicomac has become a leading global supplier of pharmaceutical equipment based on its deep roots in clean room systems and solid pharmaceutical equipment. Nicomac has its equipment applied in 65 countries around the world and has delivered more than 1800 projects, which wins it an excellent international brand image. With innovative technology and a strict control of quality, Nicomac offers efficient and reliable production solutions to the pharmaceutical industry worldwide.

As a leading enterprise in the pharmaceutical equipment industry in China, Tofflon's OSD BU is committed to the R&D and innovation of solid dosage equipment. With its strong technology research and development ability, advanced production process and perfect after-sales service, Tofflon enjoys a high reputation in the domestic and foreign markets. Besides, Tofflon has made significant achievements in solid dosage process equipment and intelligent factory, especially in their design and delivery. This cooperation has further enhanced the position of Tofflon in the solid dosage equipment market and will bring more market opportunities for both sides.

 

2. Multi-dimensional cooperation to lead the industry transformation

(A) Technological innovation: to provide cutting-edge solutions

Nicomac and Tofflon will carry out in-depth cooperation in the research and development field to jointly solve technical problems and introduce more efficient, environment-friendly and intelligent dosage equipment. Especially in the field of oral solid dosage equipment, both parties will integrate their advantages to jointly promote the innovation and upgrade of OSD equipment. In this way, the increasing demand for drug quality, production efficiency and cost control will meet.

(B) Product integration: intelligent production service upgrade

This cooperation will bring together Nicomac's advantages in equipment fields such as clean room systems and coating machines and Tofflon's expertise in intelligent systems, aiming to provide customers with a more complete one-stop solution for solid dosage. The cooperation will cover the whole process from process design to after-sales service. The two parties will work together to improve the operational efficiency for customers and promote the pharmaceutical equipment to move towards a more intelligent and automated direction.


3. Cooperation vision: create brilliant achievements together

This strategic cooperation marks the deep integration of Tofflon OSD BU and Nicomac in the field of oral solid dosage equipment, and is also a further exploration of cooperation between China and Italy in pharmaceutical equipment. Both sides indicate that they would strengthen cooperation in the future to promote global pharmaceutical equipment industry towards intelligent and environmental-friendly direction, thus improving the technology of global pharmaceutical industry. Therefore, all the pharmaceutical industry may work together to meet future challenges.


Copyright © 2020-2021 Tofflon Science and Technology Group Co., Ltd. All Rights Reserved. Shanghai ICP No.13216461 -1 Tofflon Science and Technology Group Co., Ltd.